Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Fresenius Medical Care AG's EV-to-OCF or its related term are showing as below:
XSWX:FME'
s EV-to-OCF Range Over the Past 10 Years
Min: 6.82 Med: 11.76 Max: 19.63
Current: 8.01
During the past 13 years, the highest EV-to-OCF of Fresenius Medical Care AG was 19.63. The lowest was 6.82. And the median was 11.76.
XSWX:FME's EV-to-OCF is ranked better than 51.91% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 8.665
vs XSWX:FME: 8.01
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Fresenius Medical Care AG (XSWX:FME) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Fresenius Medical Care AG's PE Ratio (TTM) for today is calculated as:
Fresenius Medical Care AG's share price for today is CHF39.25.
Fresenius Medical Care AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF3.055.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Fresenius Medical Care AG EV-to-OCF Related Terms
Fresenius Medical Care AG EV-to-OCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Fresenius Medical Care AG's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius Medical Care AG EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Fresenius Medical Care AG's EV-to-OCF falls into.
Fresenius Medical Care AG's current Enterprise Value is CHF20,135 Mil.
Fresenius Medical Care AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF2,561 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius Medical Care AG (XSWX:FME) has a EV-to-OCF of 7.86 as of Jul. 25, 2026. This is 33% below median its historical median of 11.76. Over the past decade, Fresenius Medical Care AG's EV-to-OCF has ranged from 6.82 to 19.63. According to the industry distribution chart, Fresenius Medical Care AG ranks #328 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 48.1%.
Is Fresenius Medical Care AG's EV-to-OCF too high?
Fresenius Medical Care AG's current EV-to-OCF of 7.86 is 33% below median its 10-year median of 11.76. Over the past 10 years, this metric has ranged from a low of 6.82 to a high of 19.63. The Healthcare Providers & Services industry median EV-to-OCF is 8.67. Fresenius Medical Care AG's value of 7.86 is 9.3% below this industry median. Based on the distribution chart, Fresenius Medical Care AG ranks #328 out of 682 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fresenius Medical Care AG has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's EV-to-OCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius Medical Care AG ranks #328 out of 682 companies for EV-to-OCF. This puts Fresenius Medical Care AG in the upper half of its industry. The industry median EV-to-OCF is 8.67. Fresenius Medical Care AG's value of 7.86 is 9.3% below this benchmark. Historically, Fresenius Medical Care AG's own EV-to-OCF has ranged from 6.82 to 19.63 over the past decade. While the company's 10-year median is 11.76 vs. the industry median of 8.67, Fresenius Medical Care AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.67, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius Medical Care AG's current EV-to-OCF of 7.86 is 9.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius Medical Care AG's current EV-to-OCF is 7.86, which is 33% below median its own 10-year median of 11.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Fresenius Medical Care AG (XSWX:FME) has a current EV-to-OCF of 7.86. The stock's GF Value™ is CHF37.64, compared to a current price of CHF39.25 — trading 4.3% above its estimated fair value. The current EV-to-OCF is 7.86, which is 33% below median its 10-year median of 11.76 and 9.3% below the Healthcare Providers & Services industry median of 8.67. Fresenius Medical Care AG's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Fresenius Medical Care AG (XSWX:FME), the current EV-to-OCF is 7.86 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius Medical Care AG (XSWX:FME) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be overvalued.
The current stock price of CHF39.25 is trading 4.3% above its estimated GF Value™ of CHF37.64.
Key valuation signals for XSWX:FME:
EV-to-OCF: 7.86 (33% below median its 10-year median of 11.76)
GF Value™: CHF37.64 vs. price of CHF39.25 (4.3% above fair value)
Industry Position: 9.3% below the Healthcare Providers & Services median (#328 of 682)
No single metric tells the full story. See the XSWX:FME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
75GF Score
Get the complete analysis for XSWX:FME
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FME has been successfully added to your 
